XML 33 R15.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Share-Based Compensation
6 Months Ended
Jul. 30, 2011
Share-Based Compensation

10. Share-Based Compensation

The Company accounts for share-based compensation under the provisions of ASC 718, Compensation - Stock Compensation (“ASC 718”), which requires companies to measure and recognize compensation expense for all share-based payments at fair value. Total share-based compensation expense included in the Consolidated Statements of Operations for the 13 and 26 weeks ended July 30, 2011 was $3.3 million ($2.1 million, net of tax) and $5.8 million ($3.6 million net of tax) and for the 13 and 26 weeks ended July 31, 2010 was $6.3 million ($3.9 million, net of tax) and $18.4 million ($11.3 million, net of tax), respectively.

Stock Option Grants

The Company grants both time-based and performance-based stock options under its 2005 Plan. Time-based stock option awards vest over the requisite service period of the award or to an employee’s eligible retirement date, if earlier. Performance-based stock option awards vest over three years and are earned if the Company meets pre-established performance goals during each year.

A summary of the Company’s stock option activity for the 26 weeks ended July 30, 2011 follows:

 

     Options     Weighted-Average
Exercise Price
     Weighted-Average
Remaining
Contractual

Term
     Aggregate
Intrinsic Value
 
     (In thousands)            (In years)      (In thousands)  

Outstanding - January 29, 2011

     12,124      $ 15.25         

Granted

     47      $ 15.02         

Exercised (1)

     (257   $ 10.32         

Cancelled

     (115   $ 21.65         
  

 

 

   

 

 

    

 

 

    

 

 

 

Outstanding - July 30, 2011

     11,799      $ 15.29         3.1       $ 27,178   
  

 

 

   

 

 

    

 

 

    

 

 

 

Vested and expected to vest - July 30, 2011

     11,673      $ 15.32         3.1       $ 26,956   
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable - July 30, 2011

     3,918      $ 6.91         2.0       $ 24,406   

 

(1) Options exercised during the 26 weeks ended July 30, 2011 had exercise prices ranging from $4.54 to $11.66.

The weighted-average grant date fair value of stock options granted during the 26 weeks ended July 30, 2011 and July 31, 2010 was $4.73 and $5.31, respectively. The aggregate intrinsic value of options exercised during the 26 weeks ended July 30, 2011 and July 31, 2010 was $1.3 million and $9.8 million, respectively.

Cash received from the exercise of stock options was $2.7 million for the 26 weeks ended July 30, 2011 and $4.5 million for the 26 weeks ended July 31, 2010. The actual tax benefit realized from stock option exercises totaled $0.3 million for the 26 weeks ended July 30, 2011 and $13.0 million for the 26 weeks ended July 31, 2010.

The fair value of stock options was estimated based on the closing market price of the Company’s common stock on the date of the grant using a Black-Scholes option pricing model with the following weighted-average assumptions:

 

     26 Weeks Ended  

Black-Scholes Option Valuation Assumptions

   July 30,
2011
    July 31,
2010
 

Risk-free interest rate (1)

     2.1     2.3

Dividend yield

     2.6     2.1

Volatility factor (2)

     42.7     40.2

Weighted-average expected term (3)

     5.0 years        4.5 years   

Expected forfeiture rate (4)

     8.0     8.0
 
(1) Based on the U.S. Treasury yield curve in effect at the time of grant with a term consistent with the expected life of our stock options.
(2) Based on a combination of historical volatility of the Company’s common stock and implied volatility.
(3) Represents the period of time options are expected to be outstanding, based on historical experience.
(4) Based upon historical experience.

As of July 30, 2011, there was $2.3 million of unrecognized compensation expense related to non-vested stock option awards that is expected to be recognized over a weighted average period of 1.3 years.

Restricted Stock Grants

Time-based restricted stock awards are comprised of time-based restricted stock units. These awards vest over three years; however, they may be accelerated to vest over one year if the Company meets pre-established performance goals in the year of grant. Time-based restricted stock units receive dividend equivalents in the form of additional time-based restricted stock units, which are subject to the same restrictions and forfeiture provisions as the original award.

 

Performance-based restricted stock awards include performance-based restricted stock units. These awards cliff vest at the end of a three year period based upon the Company’s achievement of pre-established goals throughout the term of the award. Performance-based restricted stock units receive dividend equivalents in the form of additional performance-based restricted stock units, which are subject to the same restrictions and forfeiture provisions as the original award. The grant date fair value of all restricted stock awards is based on the closing market price of the Company’s common stock on the date of grant.

A summary of the Company’s restricted stock activity is presented in the following tables:

 

     Time-Based Restricted Stock Units      Performance-Based Restricted Stock Units  
     26 Weeks Ended
July 30, 2011
     26 Weeks Ended
July 30, 2011
 
(Shares in thousands)    Shares     Weighted-Average Grant
Date Fair Value
     Shares     Weighted-Average Grant
Date Fair Value
 

Nonvested - January 29, 2011

     877      $ 17.45         630      $ 12.59   

Granted

     1,406        15.03         1,240        15.03   

Vested

     (372     17.45         —          —     

Cancelled

     (72     17.47         (97     15.53   
  

 

 

   

 

 

    

 

 

   

 

 

 

Nonvested - July 30, 2011

     1,839      $ 15.66         1,773      $ 14.05   

As of July 30, 2011, there was $25.7 million of unrecognized compensation expense related to non-vested time-based restricted stock unit awards that is expected to be recognized over a weighted average period of 2.3 years.

As of July 30, 2011, the Company had 25.0 million shares available for all equity grants.